Recent Advances in the Treatment of Coronary In-Stent Restenosis
In-stent restenosis (ISR) remains the predominant cause of stent failure and the most common indication for repeat revascularization. Despite technological advances in stent design, ISR continues to pose significant challenges, contributing to increased morbidity and mortality among patients undergo...
Saved in:
| Main Authors: | Luca Sartore, Mauro Gitto, Angelo Oliva, Ryota Kakizaki, Roxana Mehran, Lorenz Räber, Alessandro Spirito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2024-12-01
|
| Series: | Reviews in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/RCM/25/12/10.31083/j.rcm2512433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stent Failure Management in Contemporary Clinical Practice
by: Iosif Xenogiannis, et al.
Published: (2025-07-01) -
Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01) -
Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01) -
Drug-eluting balloon as an alternative to coronary stent in the treatment of de novo atherosclerotic lesions of native coronary arteries — the future we have already been in? Review
by: D. K. Vasiliev, et al.
Published: (2025-07-01) -
Drug-coated balloon in patients with in-stent restenosis: A prospective observational study
by: Shuvanan Ray, et al.
Published: (2025-03-01)